The Patent Finder

Panacea Pharmaceuticals, Inc.

Also on record
Records under this name other than the patents Panacea Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Back to Panacea Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 10,576,069Treatment for chemotherapy-induced cognitive impairment
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,702,591Therapeutic Cancer Vaccine Targeted to Haah (Aspartyl-[asparaginyl]-Beta-Hydroxylase
Formerly held
In force (reinstated)
 · Medium confidence
In force (reinstated)Medium confidence
US 9,744,223Therapeutic Cancer Vaccine Targeted to Haah (ASPARTYL-[ASPARAGINYL]-BETA-HYDROXYLASE)
Formerly held
In force (reinstated)
 · Low confidence
In force (reinstated)Low confidence
US 7,605,133Isolated Peptides to Treat Alpha-Synuclein Diseases
Lapsed on the fee record
Ended Oct 20, 2021 · High confidence
Lapsed on the fee recordEnded Oct 20, 2021High confidence
US 7,521,479Methods of Treating Prion Disease in Mammals
Formerly held
Term ended
Term ended Apr 16, 2021 · High confidence
Term endedTerm ended Apr 16, 2021High confidence
US 8,153,414Microbial delivery system
Formerly held
Term ended
Term ended Dec 6, 2020 · From the USPTO record
Term endedTerm ended Dec 6, 2020From the USPTO record
US 7,456,179Methods of treating ischemic related conditions
Lapsed on the fee record
Ended Nov 25, 2020 · From the USPTO record
Lapsed on the fee recordEnded Nov 25, 2020From the USPTO record
US 6,835,370Diagnosis and Treatment of Malignant Neoplasms
Formerly held
Term ended
Term ended Nov 8, 2019 · Medium confidence
Term endedTerm ended Nov 8, 2019Medium confidence
US 6,238,925Method for determining likelihood of developing clinical tolerance
Formerly held
Term ended
Term ended Jan 28, 2019 · From the USPTO record
Term endedTerm ended Jan 28, 2019From the USPTO record
US 6,780,971Compositions for Inhibiting the Aggregation Pathway of Alpha-Synuclein
Lapsed on the fee record
Ended Aug 24, 2012 · High confidence
Lapsed on the fee recordEnded Aug 24, 2012High confidence
10 of 11 patents shown.
Pro members see all 11.
Pro members: see all 11 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited